Cannabis Bioscience International Holdings (CBIH) Net Margin (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Net Margin across 5 years of filings, most recently posting 928.47% for Q1 2026.

• Net Margin for Q1 2026 came in at 928.47%, up 8758.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 431.09% (down 34337.0% YoY), and the FY2025 annual result was 184.02%, up 1576.0% from the prior year.
• Net Margin came in at 928.47% for Q1 2026 at Cannabis Bioscience International Holdings, down from 186.06% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 24.08% in Q2 2024 to a low of 1016.05% in Q1 2025.
• The 5-year median for Net Margin is 323.53% (2025), against an average of 413.01%.
• Across the five-year window, Net Margin soared 61898 bps in 2024 and tumbled 70394 bps in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Net Margin stood at 266.27% in 2022, then soared by 44 bps to 148.26% in 2023, then surged by 38 bps to 92.03% in 2024, then slumped by 102 bps to 186.06% in 2025, then slumped by 399 bps to 928.47% in 2026.
• The last three Net Margin figures came in at 928.47% (Q1 2026), 186.06% (Q4 2025), and 380.79% (Q3 2025), per Business Quant data.